Logo image of LICN

LICHEN INTERNATIONAL LTD (LICN) Stock Fundamental Analysis

NASDAQ:LICN - Nasdaq - KYG5479G1165 - Common Stock - Currency: USD

6.49  -0.14 (-2.11%)

After market: 6.49 0 (0%)

Fundamental Rating

6

LICN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. LICN gets an excellent profitability rating and is at the same time showing great financial health properties. LICN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year LICN was profitable.
In the past year LICN had a positive cash flow from operations.
LICN Yearly Net Income VS EBIT VS OCF VS FCFLICN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.67%, LICN belongs to the top of the industry, outperforming 82.93% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.10%, LICN is in line with its industry, outperforming 54.88% of the companies in the same industry.
The Return On Invested Capital of LICN (11.52%) is better than 70.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LICN is significantly above the industry average of 12.98%.
The 3 year average ROIC (18.36%) for LICN is well above the current ROIC(11.52%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 10.67%
ROE 11.1%
ROIC 11.52%
ROA(3y)16.41%
ROA(5y)N/A
ROE(3y)18.52%
ROE(5y)N/A
ROIC(3y)18.36%
ROIC(5y)N/A
LICN Yearly ROA, ROE, ROICLICN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 5 10 15 20

1.3 Margins

LICN's Profit Margin of 18.48% is amongst the best of the industry. LICN outperforms 87.80% of its industry peers.
LICN's Profit Margin has been stable in the last couple of years.
The Operating Margin of LICN (26.49%) is better than 91.46% of its industry peers.
LICN's Operating Margin has improved in the last couple of years.
LICN has a Gross Margin of 60.71%. This is in the better half of the industry: LICN outperforms 73.17% of its industry peers.
In the last couple of years the Gross Margin of LICN has remained more or less at the same level.
Industry RankSector Rank
OM 26.49%
PM (TTM) 18.48%
GM 60.71%
OM growth 3Y2.47%
OM growth 5YN/A
PM growth 3Y0.13%
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
LICN Yearly Profit, Operating, Gross MarginsLICN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LICN is creating value.
The number of shares outstanding for LICN has been increased compared to 1 year ago.
There is no outstanding debt for LICN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LICN Yearly Shares OutstandingLICN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
LICN Yearly Total Debt VS Total AssetsLICN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.90 indicates that LICN is not in any danger for bankruptcy at the moment.
LICN has a Altman-Z score of 3.90. This is in the better half of the industry: LICN outperforms 70.73% of its industry peers.
LICN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.9
ROIC/WACC1.53
WACC7.54%
LICN Yearly LT Debt VS Equity VS FCFLICN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

LICN has a Current Ratio of 17.55. This indicates that LICN is financially healthy and has no problem in meeting its short term obligations.
LICN has a Current ratio of 17.55. This is amongst the best in the industry. LICN outperforms 98.78% of its industry peers.
A Quick Ratio of 17.53 indicates that LICN has no problem at all paying its short term obligations.
LICN's Quick ratio of 17.53 is amongst the best of the industry. LICN outperforms 98.78% of its industry peers.
Industry RankSector Rank
Current Ratio 17.55
Quick Ratio 17.53
LICN Yearly Current Assets VS Current LiabilitesLICN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

LICN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 428.95%, which is quite impressive.
The Earnings Per Share has been growing by 9.78% on average over the past years. This is quite good.
Looking at the last year, LICN shows a very negative growth in Revenue. The Revenue has decreased by -15.69% in the last year.
The Revenue has been growing by 9.04% on average over the past years. This is quite good.
EPS 1Y (TTM)428.95%
EPS 3Y9.78%
EPS 5YN/A
EPS Q2Q%-51.27%
Revenue 1Y (TTM)-15.69%
Revenue growth 3Y9.04%
Revenue growth 5YN/A
Sales Q2Q%13.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LICN Yearly Revenue VS EstimatesLICN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.11, which indicates a rather cheap valuation of LICN.
Based on the Price/Earnings ratio, LICN is valued cheaply inside the industry as 98.78% of the companies are valued more expensively.
LICN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.60.
Industry RankSector Rank
PE 0.11
Fwd PE N/A
LICN Price Earnings VS Forward Price EarningsLICN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.07
LICN Per share dataLICN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The decent profitability rating of LICN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LICN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LICHEN INTERNATIONAL LTD

NASDAQ:LICN (5/20/2025, 8:12:12 PM)

After market: 6.49 0 (0%)

6.49

-0.14 (-2.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.14%
Inst Owner ChangeN/A
Ins Owners1.47%
Ins Owner ChangeN/A
Market Cap4.93M
AnalystsN/A
Price TargetN/A
Short Float %3.42%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.11
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF 1.13
P/B 0.07
P/tB 0.08
EV/EBITDA -2.07
EPS(TTM)57.83
EY891.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)5.75
OCFY88.56%
SpS55.17
BVpS91.82
TBVpS85.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.67%
ROE 11.1%
ROCE 15.92%
ROIC 11.52%
ROICexc 22.58%
ROICexgc 25.95%
OM 26.49%
PM (TTM) 18.48%
GM 60.71%
FCFM N/A
ROA(3y)16.41%
ROA(5y)N/A
ROE(3y)18.52%
ROE(5y)N/A
ROIC(3y)18.36%
ROIC(5y)N/A
ROICexc(3y)35.45%
ROICexc(5y)N/A
ROICexgc(3y)44.68%
ROICexgc(5y)N/A
ROCE(3y)25.47%
ROCE(5y)N/A
ROICexcg growth 3Y-13.48%
ROICexcg growth 5YN/A
ROICexc growth 3Y-8.86%
ROICexc growth 5YN/A
OM growth 3Y2.47%
OM growth 5YN/A
PM growth 3Y0.13%
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 150.24%
Cap/Sales 10.58%
Interest Coverage 250
Cash Conversion 31.06%
Profit Quality N/A
Current Ratio 17.55
Quick Ratio 17.53
Altman-Z 3.9
F-Score5
WACC7.54%
ROIC/WACC1.53
Cap/Depr(3y)98.71%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.25%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)428.95%
EPS 3Y9.78%
EPS 5YN/A
EPS Q2Q%-51.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.69%
Revenue growth 3Y9.04%
Revenue growth 5YN/A
Sales Q2Q%13.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.71%
EBIT growth 3Y11.74%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-100.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.03%
OCF growth 3Y-59.44%
OCF growth 5YN/A